Literature DB >> 34665326

Parachute technique for portal vein reconstruction during pancreaticoduodenectomy with portal vein resection in patients with pancreatic head cancer.

Shoichi Irie1,2, Ryuji Yoshioka1, Hiroshi Imamura1, Yoshihiro Ono2, Takafumi Sato2, Yosuke Inoue2, Hiromichi Ito2, Yoshihiro Mise1,2, Yu Takahashi2, Akio Saiura3,4.   

Abstract

BACKGROUND: The most appropriate venous reconstruction method remains debatable when a long section of portal vein (PV) and/or superior mesenteric vein (SMV) must be resected in patients undergoing a pancreaticoduodenectomy (PD). The aim of the present study was to describe the technical details of the parachute technique, a modified end-to-end anastomotic maneuver that can be used in the above-mentioned circumstances, and to investigate its safety and feasibility. STUDY
DESIGN: Patients who underwent venous reconstruction using the parachute technique after receiving a PD with PV resection for pancreatic cancer between January 2014 and March 2019 were retrospectively reviewed. For the parachute technique, the posterior wall was sutured in a continuous fashion while the stitches were left untightened. The stitches were then tightened from both sides after the running suture of the posterior wall had been completed, thereby dispersing the tension applied to the stitched venous wall when the venous ends were brought together and solving any problems that would otherwise have been caused by over-tension. The postoperative outcomes and PV patency were then investigated.
RESULTS: Fifteen patients were identified. The median length of the resected PV/SMV measured in vivo was 5 cm (range, 3-6 cm). The splenic vein was resected in all the patients and was reconstructed in 13 patients (87%). The overall postoperative complication rate (≥ Clavien-Dindo grade I) was 60%, while a major complication (≥ Clavien-Dindo grade IIIa) occurred in 1 patient (7%). No postoperative deaths occurred in this series. The PV patency at 1 year was 87%.
CONCLUSION: The parachute technique is both safe and feasible and is a simple venous reconstruction procedure suitable for use in cases undergoing PD when the distance between the resected PV and SMV is relatively long.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Pancreas head cancer; Pancreatic cancer; Pancreaticoduodenectomy; Parachute technique; Portal vein resection; Venous reconstruction

Mesh:

Year:  2021        PMID: 34665326     DOI: 10.1007/s00423-021-02338-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  30 in total

1.  Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.

Authors:  Y Murakami; S Satoi; F Motoi; M Sho; M Kawai; I Matsumoto; G Honda
Journal:  Br J Surg       Date:  2015-04-15       Impact factor: 6.939

2.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Authors:  Thierry Conroy; Pascal Hammel; Mohamed Hebbar; Meher Ben Abdelghani; Alice C Wei; Jean-Luc Raoul; Laurence Choné; Eric Francois; Pascal Artru; James J Biagi; Thierry Lecomte; Eric Assenat; Roger Faroux; Marc Ychou; Julien Volet; Alain Sauvanet; Gilles Breysacher; Frédéric Di Fiore; Christine Cripps; Petr Kavan; Patrick Texereau; Karine Bouhier-Leporrier; Faiza Khemissa-Akouz; Jean-Louis Legoux; Béata Juzyna; Sophie Gourgou; Christopher J O'Callaghan; Claire Jouffroy-Zeller; Patrick Rat; David Malka; Florence Castan; Jean-Baptiste Bachet
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

3.  Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy.

Authors:  D Kleive; M A Sahakyan; A E Berstad; C S Verbeke; I P Gladhaug; B Edwin; B Fosby; P-D Line; K J Labori
Journal:  Br J Surg       Date:  2017-08-17       Impact factor: 6.939

4.  Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.

Authors:  Tsutomu Fujii; Akimasa Nakao; Suguru Yamada; Masaya Suenaga; Masashi Hattori; Hideki Takami; Yoshikuni Inokawa; Mitsuro Kanda; Hiroyuki Sugimoto; Shuji Nomoto; Kenta Murotani; Yasuhiro Kodera
Journal:  Surgery       Date:  2015-02-20       Impact factor: 3.982

Review 5.  Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer.

Authors:  George Younan; Susan Tsai; Douglas B Evans; Kathleen K Christians
Journal:  Surg Clin North Am       Date:  2016-10-14       Impact factor: 2.741

6.  Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy.

Authors:  Frank Wang; Ranjan Arianayagam; Anthony Gill; Vikram Puttaswamy; Michael Neale; Sivakumar Gananadha; Thomas J Hugh; Jaswinder S Samra
Journal:  J Am Coll Surg       Date:  2012-07-03       Impact factor: 6.113

7.  Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Authors:  John P Neoptolemos; Daniel H Palmer; Paula Ghaneh; Eftychia E Psarelli; Juan W Valle; Christopher M Halloran; Olusola Faluyi; Derek A O'Reilly; David Cunningham; Jonathan Wadsley; Suzanne Darby; Tim Meyer; Roopinder Gillmore; Alan Anthoney; Pehr Lind; Bengt Glimelius; Stephen Falk; Jakob R Izbicki; Gary William Middleton; Sebastian Cummins; Paul J Ross; Harpreet Wasan; Alec McDonald; Tom Crosby; Yuk Ting Ma; Kinnari Patel; David Sherriff; Rubin Soomal; David Borg; Sharmila Sothi; Pascal Hammel; Thilo Hackert; Richard Jackson; Markus W Büchler
Journal:  Lancet       Date:  2017-01-25       Impact factor: 79.321

8.  Pancreatic Cancer Surgery: The New R-status Counts.

Authors:  Oliver Strobel; Thomas Hank; Ulf Hinz; Frank Bergmann; Lutz Schneider; Christoph Springfeld; Dirk Jäger; Peter Schirmacher; Thilo Hackert; Markus W Büchler
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

9.  Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Authors:  Katsuhiko Uesaka; Narikazu Boku; Akira Fukutomi; Yukiyasu Okamura; Masaru Konishi; Ippei Matsumoto; Yuji Kaneoka; Yasuhiro Shimizu; Shoji Nakamori; Hirohiko Sakamoto; Soichiro Morinaga; Osamu Kainuma; Koji Imai; Naohiro Sata; Shoichi Hishinuma; Hitoshi Ojima; Ryuzo Yamaguchi; Satoshi Hirano; Takeshi Sudo; Yasuo Ohashi
Journal:  Lancet       Date:  2016-06-02       Impact factor: 79.321

Review 10.  Local radicality and survival outcome of pancreatic cancer surgery.

Authors:  Willem Niesen; Thomas Hank; Markus Büchler; Oliver Strobel
Journal:  Ann Gastroenterol Surg       Date:  2019-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.